Which papillary thyroid cancer variants are associated with a poorer prognosis?

Prepare for the Rosh Internal Medicine Exam with quizzes, flashcards, and multiple-choice questions, complete with hints and explanations. Get ready to excel on your exam!

Multiple Choice

Which papillary thyroid cancer variants are associated with a poorer prognosis?

Explanation:
Papillary thyroid carcinomas vary in aggressiveness, and certain histologic patterns are linked to worse outcomes. The tall cell, insular, and hobnail variants are recognized as more aggressive forms of papillary thyroid cancer. They tend to show higher-grade features such as greater invasion beyond the thyroid, more frequent lymph node involvement, and a higher chance of recurrence, which translates into a poorer overall prognosis compared with the more typical or well-differentiated variants. In contrast, the classical variant and the follicular variant generally behave less aggressively and are associated with better long-term outcomes, especially when detected at a small size. Microcarcinomas, by definition ≤1 cm, almost always have an excellent prognosis and often require less aggressive management.

Papillary thyroid carcinomas vary in aggressiveness, and certain histologic patterns are linked to worse outcomes. The tall cell, insular, and hobnail variants are recognized as more aggressive forms of papillary thyroid cancer. They tend to show higher-grade features such as greater invasion beyond the thyroid, more frequent lymph node involvement, and a higher chance of recurrence, which translates into a poorer overall prognosis compared with the more typical or well-differentiated variants.

In contrast, the classical variant and the follicular variant generally behave less aggressively and are associated with better long-term outcomes, especially when detected at a small size. Microcarcinomas, by definition ≤1 cm, almost always have an excellent prognosis and often require less aggressive management.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy